The RAPS learning platform provider will be upgrading its security posture. This will take the system off-line from 20 July through the end of the day 23 July. This will affect any Online Course, eBook, and Virtual Program Attendance. Thank you for your patience.
In Focus: Risks and Rewards
Posted 01 September 2011 | By
The September issue of Regulatory Focus considers various systems used to assess and manage the risks and potential hazards associated with developing medical products. Monitoring risk is an essential component in both the medical device and drug development arenas. Medical device and pharmaceutical companies need to have appropriate programs in place to evaluate potential risks associated with their products as well as mechanisms (e.g., inquiries, complaints, market studies, focus groups, servicing) to capture customer feedback regarding product use.